Altor Investor Seeks Appraisal After $290M NantCell Deal
An investor in Altor BioScience LLC filed an appraisal petition Tuesday in Delaware Chancery Court seeking a court valuation of its shares in the biopharmaceutical company after a $290 million merger...To view the full article, register now.
Already a subscriber? Click here to view full article